Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study

BACKGROUND: Correct identification of the fibrosis progression risk is a critical step in the management of patients with type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), because liver fibrosis, especially advanced liver fibrosis, is difficult to reverse. However, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Jinying, Jin, Guang, Hua, Qifeng, Cui, Shihan, Li, Jianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273858/
https://www.ncbi.nlm.nih.gov/pubmed/35837300
http://dx.doi.org/10.3389/fendo.2022.917304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273858/
https://www.ncbi.nlm.nih.gov/pubmed/35837300
http://dx.doi.org/10.3389/fendo.2022.917304

Ejemplares similares